name: Electroencephalogram (EEG), without video, review of data, technical description by EEG technologist, each increment of 12-26 hours; with intermittent monitoring and maintenance


name: Electroencephalogram (EEG), without video, review of data, technical description by EEG technologist, each increment of 12-26 hours; with continuous, real-time monitoring and maintenance


name: Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, 2-12 hours


name: Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, 2-12 hours; unmonitored


name: Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, 2-12 hours; with intermittent monitoring and maintenance


name: Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, 2-12 hours; with continuous, real-time monitoring and maintenance


name: Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, each increment of 12-26 hours


name: Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, each increment of 12-26 hours; unmonitored


name: Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, each increment of 12-26 hours; with intermittent monitoring and maintenance


name: Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, each increment of 12-26 hours; with continuous, real-time monitoring and maintenance


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation and report, 2-12 hours of EEG recording


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation and report, 2-12 hours of EEG recording; without video


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation and report, 2-12 hours of EEG recording; with video (VEEG)


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; without video


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG)


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 36 hours, up to 60 hours of EEG recording, without video


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 36 hours, up to 60 hours of EEG recording, with video (VEEG)


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 60 hours, up to 84 hours of EEG recording, without video


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 60 hours, up to 84 hours of EEG recording, with video (VEEG)


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 84 hours of EEG recording, without video


name: Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 84 hours of EEG recording, with video (VEEG)


name: Health behavior assessment, or re-assessment (ie, health-focused clinical interview, behavioral observations, clinical decision making)


name: Health behavior intervention, individual, face-to-face


name: Health behavior intervention, individual, face-to-face; initial 30 minutes


name: Health behavior intervention, individual, face-to-face; each additional 15 minutes (List separately in addition to code for primary service)


name: Face-to-face individual health behavior intervention, each additional 15 minutes


name: Health behavior intervention, group (2 or more patients), face-to-face


name: Health behavior intervention, group (2 or more patients), face-to-face; initial 30 minutes


name: Face-to-face group health behavior intervention, initial 30 minutes


name: Health behavior intervention, group (2 or more patients), face-to-face; each additional 15 minutes (List separately in addition to code for primary service)


name: Face-to-face group health behavior intervention, each additional 15 minutes


name: Health behavior intervention, family (with the patient present), face-to-face


name: Health behavior intervention, family (with the patient present), face-to-face; initial 30 minutes


name: Health behavior intervention, family (with the patient present), face-to-face; each additional 15 minutes (List separately in addition to code for primary service)


name: Face-to-face family (with patient present) health behavior intervention, each additional 15 minutes


name: Health behavior intervention, family (without the patient present), face-to-face


name: Health behavior intervention, family (without the patient present), face-to-face; initial 30 minutes


name: Health behavior intervention, family (without the patient present), face-to-face; each additional 15 minutes (List separately in addition to code for primary service)


name: Face-to-face family (without patient present) health behavior intervention, each additional 15 minutes


name: Therapeutic interventions that focus on cognitive function (eg, attention, memory, reasoning, executive function, problem solving, and/or pragmatic functioning) and compensatory strategies to manage the performance of an activity (eg, managing time or schedules, initiating, organizing, and sequencing tasks), direct (one-on-one) patient contact


name: Therapeutic interventions that focus on cognitive function (eg, attention, memory, reasoning, executive function, problem solving, and/or pragmatic functioning) and compensatory strategies to manage the performance of an activity (eg, managing time or schedules, initiating, organizing, and sequencing tasks), direct (one-on-one) patient contact; initial 15 minutes


name: Therapeutic interventions that focus on cognitive function and compensatory strategies to manage the performance of an activity, direct (one-on-one) patient contact, initial 15 minutes


name: Therapeutic interventions that focus on cognitive function (eg, attention, memory, reasoning, executive function, problem solving, and/or pragmatic functioning) and compensatory strategies to manage the performance of an activity (eg, managing time or schedules, initiating, organizing, and sequencing tasks), direct (one-on-one) patient contact; each additional 15 minutes (List separately in addition to code for primary procedure)


name: Therapeutic interventions that focus on cognitive function and compensatory strategies to manage the performance of an activity, direct (one-on-one) patient contact, each additional 15 minutes


name: Qualified nonphysician health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes


name: Self-measured blood pressure using a device validated for clinical accuracy


name: Self-measured blood pressure using a device validated for clinical accuracy; patient education/training and device calibration


name: Self-measured blood pressure using a device validated for clinical accuracy; separate self-measurements of two readings one minute apart, twice daily over a 30-day period (minimum of 12 readings), collection of data reported by the patient and/or caregiver to the physician or other qualified health care professional, with report of average systolic and diastolic pressures and subsequent communication of a treatment plan to the patient


name: Self measured blood pressure measurements


name: Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days


name: Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes


name: Online digital evaluation and management service, for established patient, for up to 7 days, cumulative time 5-10 minutes


name: Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes


name: Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes


name: Online digital evaluation and management service, for established patient, for up to 7 days, cumulative time 21 or more minutes


name: Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month


name: Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; each additional 20 minutes (List separately in addition to code for primary procedure)


name: Remote physiologic monitoring treatment management services, health care professional time in calendar month requiring interactive communication with the patient/caregiver, each additional 20 minutes


name: Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed


name: Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed; without evidence of retinopathy (DM)


name: 7 standard field stereoscopic retinal photos with interpretation by an ophthalmologist or optometrist documented and reviewed


name: 7 standard field stereoscopic retinal photos with interpretation by an ophthalmologist or optometrist documented and reviewed; without evidence of retinopathy (DM)


name: Eye imaging validated to match diagnosis from 7 standard field stereoscopic retinal photos results documented and reviewed


name: Eye imaging validated to match diagnosis from 7 standard field stereoscopic retinal photos results documented and reviewed; without evidence of retinopathy (DM)


name: Transapical mitral valve repair, including transthoracic echocardiography, when performed, with placement of artificial chordae tendineae


name: Repair of valve between upper left and lower left chambers of heart (mitral valve) with insertion of artificial supporting tendons, accessed through apex of heart


name: Transcatheter mitral valve annulus reconstruction, with implantation of adjustable annulus reconstruction device, percutaneous approach including transseptal puncture


name: Reconstruction of junction between upper left and lower left chambers of heart (annulus of mitral valve) with implantation of adjustable reconstruction device, via catheter, accessed through skin


name: Transcatheter tricuspid valve annulus reconstruction with implantation of adjustable annulus reconstruction device, percutaneous approach


name: Reconstruction of junction between upper right and lower right chambers of heart (annulus of tricuspid valve) with implantation of adjustable reconstruction device, via catheter, accessed through skin


name: Radiofrequency spectroscopy, real time, intraoperative margin assessment, at the time of partial mastectomy, with report


name: Radiofrequency spectroscopy evaluation of surgical margins during partial mastectomy, with report


name: Bone-material quality testing by microindentation(s) of the tibia(s), with results reported as a score


name: Bone material quality testing by microindentations of shin bone


name: Periurethral transperineal adjustable balloon continence device; bilateral insertion, including cystourethroscopy and imaging guidance


name: Periurethral transperineal adjustable balloon continence device; unilateral insertion, including cystourethroscopy and imaging guidance


name: Periurethral transperineal adjustable balloon continence device; removal, each balloon


name: Periurethral transperineal adjustable balloon continence device; percutaneous adjustment of balloon(s) fluid volume


name: Low-level laser therapy, dynamic photonic and dynamic thermokinetic energies, provided by a physician or other qualified health care professional


name: Percutaneous transcatheter placement of iliac arteriovenous anastomosis implant, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention


name: Insertion of implant connecting groin artery and groin vein, with radiological supervision and interpretation and imaging guidance, via catheter, accessed through skin


name: Bone strength and fracture risk using finite element analysis of functional data and bone-mineral density utilizing data from a computed tomography scan


name: Bone strength and fracture risk using finite element analysis of functional data and bone-mineral density utilizing data from a computed tomography scan; retrieval and transmission of the scan data, assessment of bone strength and fracture risk and bone-mineral density, interpretation and report


name: Bone strength and fracture risk assessment: retrieval and transmission of CT scan data, assessment of bone strength and fracture risk and bone mineral density, interpretation and report


name: Bone strength and fracture risk using finite element analysis of functional data and bone-mineral density utilizing data from a computed tomography scan; retrieval and transmission of the scan data


name: Bone strength and fracture risk assessment: retrieval and transmission of CT scan data only


name: Bone strength and fracture risk using finite element analysis of functional data and bone-mineral density utilizing data from a computed tomography scan; assessment of bone strength and fracture risk and bone-mineral density


name: Bone strength and fracture risk assessment: assessment of bone strength and fracture risk and bone mineral density


name: Bone strength and fracture risk using finite element analysis of functional data and bone-mineral density utilizing data from a computed tomography scan; interpretation and report


name: Bone strength and fracture risk assessment: interpretation and report


name: Computed tomography scan taken for the purpose of biomechanical computed tomography analysis


name: CT scan for biomechanical computed tomography analysis


name: Anatomic model 3D-printed from image data set(s)


name: Anatomic model 3D-printed from image data set(s); first individually prepared and processed component of an anatomic structure


name: 3-D printed anatomic model; first individually prepared and processed component of anatomic structure


name: Anatomic model 3D-printed from image data set(s); each additional individually prepared and processed component of an anatomic structure (List separately in addition to code for primary procedure)


name: 3-D printed anatomic model; each additional individually prepared and processed component of anatomic structure


name: Anatomic guide 3D-printed and designed from image data set(s)


name: Anatomic guide 3D-printed and designed from image data set(s); first anatomic guide


name: Anatomic guide 3D-printed and designed from image data set(s); each additional anatomic guide (List separately in addition to code for primary procedure)


name: 3-D printed anatomic guide; each additional guide


name: Evacuation of meibomian glands, using heat delivered through wearable, open-eye eyelid treatment devices and manual gland expression, bilateral


name: Evacuation of meibomian tear glands of eyelids of both eyes


name: Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on percent of cytotoxicity observed, a minimum of 14 drugs or drug combinations


name: Evaluation of toxicity of chemotherapy drugs on cancer stem cells


name: Autologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees


name: Autologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; tissue harvesting and cellular implant creation


name: Harvesting of fatty tissue and creation of cellular implant for treatment of osteoarthritis


name: Autologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; injection of cellular implant into knee joint including ultrasound guidance, unilateral


name: Injection of fatty tissue cellular implant for treatment of osteoarthritis in knee, using ultrasound guidance


name: Permanent fallopian tube occlusion with degradable biopolymer implant, transcervical approach, including transvaginal ultrasound


name: Blockage of fallopian tubes with implants inserted through cervix


name: Introduction of mixture of saline and air for sonosalpingography to confirm occlusion of fallopian tubes, transcervical approach, including transvaginal ultrasound and pelvic ultrasound


name: Introduction of saline and air into fallopian tubes to test for blockage


name: transcatheter tricuspid valve repair, percutaneous approach


name: Transcatheter tricuspid valve repair, percutaneous approach; initial prosthesis


name: Repair of valve between upper right and lower right chambers of heart (tricuspid valve) using prosthesis delivered via catheter, accessed through skin; initial prosthesis


name: Transcatheter tricuspid valve repair, percutaneous approach; each additional prosthesis during same session (List separately in addition to code for primary procedure)


name: Repair of valve between upper right and lower right chambers of heart (tricuspid valve) using prosthesis delivered via catheter, accessed through skin; each additional prosthesis


name: Insertion or replacement of implantable cardioverter-defibrillator system with substernal electrode(s), including all imaging guidance and electrophysiological evaluation (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters), when performed


name: Insertion or replacement of implantable cardioverter-defibrillator system with electrodes under breastbone


name: Insertion of substernal implantable defibrillator electrode


name: Insertion of implantable defibrillator electrode under breastbone


name: Removal of substernal implantable defibrillator electrode


name: Removal of implantable defibrillator electrode from under breastbone


name: Repositioning of previously implanted substernal implantable defibrillator-pacing electrode


name: Repositioning of previously implanted defibrillator electrode under breastbone


name: Programming device evaluation (in person) of implantable cardioverter-defibrillator system with substernal electrode, with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional


name: In-person programming device evaluation of implantable cardioverter-defibrillator system with electrode under breastbone, with analysis, review and report


name: Interrogation device evaluation (in person) of implantable cardioverter-defibrillator system with substernal electrode, with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter


name: In-person interrogation device evaluation of implantable cardioverter-defibrillator system with electrode under breastbone, with analysis, review and report


name: Electrophysiologic evaluation of implantable cardioverter-defibrillator system with substernal electrode (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters)


name: Electrophysiological evaluation of implantable cardioverter-defibrillator system with electrode under breastbone, with analysis, review and report


name: Interrogation device evaluation(s) (remote), up to 90 days, substernal lead implantable cardioverter-defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional


name: Remote interrogation device evaluation of implantable cardioverter-defibrillator system with lead under breastbone, with analysis, review and report by healthcare professional


name: Interrogation device evaluation(s) (remote), up to 90 days, substernal lead implantable cardioverter-defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results


name: Remote interrogation device evaluation of implantable cardioverter-defibrillator system with lead under breastbone, with remote data acquisitions, receipt of transmissions and technician review, technical support and distribution of results


name: Removal of substernal implantable defibrillator pulse generator only


name: Removal of implantable defibrillator pulse generator from under breastbone


name: Ablation, malignant breast tumor(s), percutaneous, cryotherapy, including imaging guidance when performed, unilateral


name: Freezing destruction of malignant breast tumors in one breast, accessed through skin


name: Transurethral ablation of malignant prostate tissue by high-energy water vapor thermotherapy, including intraoperative imaging and needle guidance


name: High-energy water vapor heat destruction of malignant prostate tissue, including imaging and needle guidance


name: Tympanostomy (requiring insertion of ventilating tube), using an automated tube delivery system, iontophoresis local anesthesia


name: Insertion of ventilating tube in eardrum using an automated tube delivery system under local anesthesia


name: Islet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when performed


name: Islet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when performed; percutaneous


name: Transplantation of insulin-producing cells, via catheter accessed through skin using imaging guidance


name: Islet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when performed; laparoscopic


name: Transplantation of insulin-producing cells using endoscope inserted through wall of abdomen


name: Islet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when performed; open


name: Transplantation of insulin-producing cells, open procedure


name: Percutaneous implantation or replacement of integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming, and imaging guidance when performed, posterior tibial nerve


name: Revision or removal of percutaneously placed integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming, and imaging guidance when performed, posterior tibial nerve


name: Electronic analysis with simple programming of implanted integrated neurostimulation system for bladder dysfunction (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, posterior tibial nerve, 1-3 parameters


name: Electronic analysis with complex programming of implanted integrated neurostimulation system for bladder dysfunction (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, posterior tibial nerve, 4 or more parameters


name: face-to-face health and well-being coaching


name: Health and well-being coaching face-to-face; individual, initial assessment


name: Health and well-being coaching face-to-face; individual, follow-up session, at least 30 minutes


name: Health and well-being coaching face-to-face; group (2 or more individuals), at least 30 minutes


name: Face-to-face health and well-being coaching of group, at least 30 minutes


name: Multianalyte Assays with Algorithmic Analyses and Proprietary Laboratory Analyses


name: Immobilized Metal Affinity Chromatography


name: Stable Isotope Labeling with Amino Acids in Cell Culture


name: Chemokine (C-C Motif) Ligand 20 Measurement


name: Montreal Cognitive Assessment Naming Test


name: Chemokine (C-X-C Motif) Ligand 11 Measurement


name: Unspecified Cells to Leukocytes Ratio Measurement


name: Montreal Cognitive Assessment Orientation Test


name: CDISC SDTM Implementation Guide Version 3.2


name: CDISC SDTM Implementation Guide Version 3.3


name: Urinary System Findings Completion Status


name: Human Immunodeficiency Virus Measurement


name: Caregiver Oncology Needs Evaluation Tool


name: Chemokine (C-X3-C Motif) Ligand 1 Measurement


name: Erythrocyte Inclusion Bodies Measurement


name: Stereotactic Accelerated Partial Breast Irradiation


name: Montreal Cognitive Assessment Abstraction Test


name: Adjacent Tissue Transfer or Rearrangement


name: Mental health screening report:Find:Pt:^Patient:Doc


name: Guidance for percutaneous biopsy of Liver


name: PhenX - complete blood count protocol 220501:-:Pt:^Patient:-:PhenX


name: PhenX - complete blood count protocol 220501


name: {1 (0.1 ML) (diazepam 100 MG/ML Nasal Spray [Valtoco]) } Pack [Valtoco 10 MG Dose Kit]


name: {2 (0.1 ML) (diazepam 100 MG/ML Nasal Spray [Valtoco]) } Pack [Valtoco 20 MG Dose Kit]


name: Somatic symptom disorder score:Score:Pt:^Patient:Qn


name: Somatic symptom disorder screening report:Find:Pt:^Patient:Doc


name: Somatic symptom disorder screening report


name: Appointment of legal guardian:Find:Pt:^Patient:Nom


name: ADHD question consistency score:Score:Pt:^Patient:Qn


name: Megalencephaly Cutis Marmorata Telangiectatica Congenita (test kit)


name: Measured weight loss (observable entity)


name: Growth hormone receptor antagonist (disposition)


name: Accessibility of home entrance:Find:Pt:^Patient:Nom


name: Accessibility of home interior:Find:Pt:^Patient:Nom


name: Non-specific active suicidal thoughts:Find:Lifetime:^Patient:Ord


name: WellRx Questionnaire - revised:-:Pt:^Patient:-:WellRx


name: CD19 blasts/100 blasts in blood (lab test)


name: CT Guidance for injection of Joint space


name: CT Guidance for drainage and placement of drainage catheter of appendix


name: MR Guidance for stereotactic biopsy of Brain


name: Substance with acetylcholinesterase reactivator mechanism of action (substance)


name: Product containing vasopressin receptor agonist (product)


name: Vasopressin receptor agonist (disposition)


name: Product containing smoothened receptor agonist (product)


name: Smoothened receptor agonist (disposition)


name: Substance with sodium-hydrogen exchanger isoform 3 transporter inhibitor mechanism of action (substance)


name: Guidance for kyphoplasty of Lumbar spine


name: ADHD hyperactive symptoms severity:Imp:Pt:^Patient:Ord


name: ADHD inattentive symptoms severity:Imp:Pt:^Patient:Ord


name: Advance directive document format:Find:Pt:^Patient:Nom


name: Wish to be dead:Find:Lifetime:^Patient:Ord


name: CT Guidance for drainage and placement of drainage catheter of pancreas


name: CD127 blasts/100 blasts in blood (lab test)


name: Drug classes of medications taken:Type:Pt:^Patient:Nom


name: Genetic risk score for coronary heart disease:Score:Lifetime:^Patient:Qn


name: Home accessibility modification date:Date:Pt:^Patient:Qn


name: CT Guidance for drainage and placement of drainage catheter of subphrenic space


name: Dermatan sulfate & heparan sulfate & keratan sulfate panel


name: Dermatan sulfate & heparan sulfate & keratan sulfate panel:-:Pt:Ser/Plas:-


name: little c Ag^during infancy:PrThr:Pt:RBC:Ord


name: HEDIS 2020 Value Set - Mammography:-:Pt:^Patient:-


name: Total parenteral nutrition agent (substance)


name: Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel:-:Pt:^Patient:-


name: Comparison with previous results:Find:Pt:^Patient:Doc


name: PhenX - bone age protocol 220301:-:Pt:^Patient:-:PhenX


name: Body disposition facility name:ID:Pt:Facility:Nom


name: CD11c+CD19+ cells/100 cells in bone marrow


name: cytoplasmic CD22 blasts/100 blasts in blood


name: cytoplasmic CD13 blasts/100 blasts in blood


name: Sodium-hydrogen exchanger isoform 3 transporter inhibitor (disposition)


name: {28 (tolvaptan 15 MG Oral Tablet [Jynarque]) / 28 (tolvaptan 30 MG Oral Tablet [Jynarque]) } Pack [Jynarque 30/15 Carton]


name: {56 (tolvaptan 15 MG Oral Tablet [Jynarque]) } Pack [Jynarque 15/15 Carton]


name: CD11c+CD19+ cells/100 cells in cerebral spinal fluid


name: E Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: little e Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: Substance use disorder screening report:Find:Pt:^Patient:Doc


name: Cause of sick feeling:Find:Pt:^Patient:Nom


name: CD11c+CD19+ cells/100 cells in body fluid


name: CD11c+CD19+ cells/100 cells in tissue (lab test)


name: CD123 blasts/100 blasts in blood (lab test)


name: Best thing about your day:Find:Pt:^Patient:Nom


name: Body disposition facility address:Addr:Pt:Facility:Nom


name: Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel


name: Date and time of obstetric delivery:TmStp:Pt:^Patient:Qn


name: Date of most lethal suicide attempt:Date:Pt:^Patient:Qn


name: Date of most recent suicide attempt:Date:Pt:^Patient:Qn


name: CD14 blasts/100 blasts in blood (lab test)


name: CD16 blasts/100 blasts in blood (lab test)


name: CD1a blasts/100 blasts in blood (lab test)


name: Central alpha-2 adrenergic receptor agonist (disposition)


name: Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)


name: little c Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: C Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: C Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: little c Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: DPYD gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: little e Ag^during infancy:PrThr:Pt:RBC:Ord


name: E Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: little e Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: CT Guidance for drainage and placement of drainage catheter of abdomen


name: CT Guidance for drainage and placement of drainage catheter of anus


name: CT Guidance for drainage and placement of drainage catheter of biliary ducts and gallbladder


name: CT Guidance for drainage and placement of drainage catheter of chest


name: CT Guidance for drainage and placement of drainage catheter of gallbladder


name: CT Guidance for drainage and placement of drainage catheter of kidney


name: CT Guidance for drainage and placement of drainage catheter of liver


name: CT Guidance for drainage and placement of drainage catheter of pelvis


name: CT Guidance for drainage and placement of drainage catheter of retroperitoneum


name: CT Guidance for exchange of nephrostomy tube of Kidney


name: CT guidance for fluid aspiration of breast


name: CT guidance for fluid aspiration of cervical spine intervertebral disc


name: CT guidance for fluid aspiration of chest


name: CT guidance for fluid aspiration of liver


name: CT guidance for fluid aspiration of lung


name: CT guidance for fluid aspiration of neck


name: CT guidance for fluid aspiration of pancreas


name: CT guidance for fluid aspiration of pleural space


name: CT Guidance for injection of Cervical spine Intervertebral disc


name: CT Guidance for localization of placenta of Uterus


name: CT guidance for needle localization of breast


name: CT guidance for needle localization of cervical spine


name: CT Guidance for needle localization of Lumbar spine


name: CT Guidance for needle localization of Thoracic spine


name: CT Guidance for percutaneous replacement of drainage tube of Abdomen


name: CT Guidance for percutaneous replacement of drainage tube of Pelvis


name: CT Guidance for percutaneous vertebroplasty of Lumbar spine


name: CT Guidance for percutaneous vertebroplasty of Thoracic spine


name: CT Guidance for placement of nephrostomy tube in Kidney


name: cytoplasmic CD179a blasts/100 blasts in blood


name: Guidance for drainage and placement of chest tube of Pleural space


name: Guidance for injection of Spine epidural space


name: Guidance for injection of Temporomandibular joint


name: Guidance for kyphoplasty of Thoracic spine


name: Guidance for percutaneous biopsy of Kidney


name: HEDIS 2020 Value Set - Urine Protein Tests


name: HEDIS 2020 Value Set - Urine Protein Tests:-:Pt:^Patient:-


name: Home accessibility evaluation status:Find:Pt:^Patient:Nom


name: Home accessibility modification panel:-:Pt:^Patient:-


name: Home accessibility modification responsible party:Find:Pt:^Patient:Nom


name: Home accessibility modification responsible party


name: HEDIS 2020 Value Set - BMI:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - BMI percentile:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - CT Colonography:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - Diastolic Blood Pressure:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - Diastolic Blood Pressure


name: HEDIS 2020 Value Set - Systolic Blood Pressure:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - Systolic Blood Pressure


name: Setting of exposure to environmental or occupational hazard:Type:Pt:^Patient:Nom


name: Lifetime risk for developing coronary heart disease based on genetic risk score:Likelihood:Lifetime:^Patient:Ord


name: Somatic symptom disorder severity:Imp:Pt:^Patient:Ord


name: Substance use disorder question consistency score:Score:Pt:^Patient:Qn


name: Substance use disorder score:Score:Pt:^Patient:Qn


name: Medical records in response to authorization denial


name: Medical records in response to authorization denial:Find:Pt:^Patient:Doc


name: Substance use disorder severity:Imp:Pt:^Patient:Ord


name: Insertion of composite restoration using strip crown


name: Healthy Eating Index 2015 (assessment scale)


name: Monocyte chemotactic protein-2 measurement


name: Discharge/discontinuation of the episode of care documented in the medical record (M1009)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1012)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1014)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1011)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1010)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1013)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1015)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1112)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1107)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1122)


name: The start of an episode of care documented in the medical record (M1135)


name: The start of an episode of care documented in the medical record (M1111)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1137)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1117)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1127)


name: The start of an episode of care documented in the medical record (M1121)


name: The start of an episode of care documented in the medical record (M1106)


name: The start of an episode of care documented in the medical record (M1136)


name: The start of an episode of care documented in the medical record (M1116)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1131)


name: The start of an episode of care documented in the medical record (M1126)


name: Was Menopausal Hormone Therapy Ever Used


name: Was another Form of Birth Control Ever Used


name: Have Oral Contraceptives Ever Been Taken


name: Date and Method of Initial Pathologic Diagnosis


name: Date of Tumor Progression After Initial Treatment


name: Date of Tumor Reoccurrence After Initial Treatment


name: Did the Individual have Multiple Known Primary Tumors at Initial Melanoma Diagnosis


name: What is the First Course Treatment Completion Measure of Success of Outcome


name: Did a New Event Occur After Initial Treatment


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Additional Surgery for New Tumor Event Loco-Regional


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Additional Surgery for New Tumor Event Metastasis


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Tumor Progression after Initial Treatment


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Tumor Reoccurrence After Initial Treatment


name: Number of Discontiguous Lesions (New Tumor Event)


name: Number of Known Primaries at the Time of Initial Melanoma Diagnosis


name: Number of Other Lymph Nodes Positive for Tumor by H&E


name: Number of Other Lymph Nodes Positive for Tumor by IHC staining only


name: Number of Para-aortic Lymph Nodes Examined


name: Number of Para-aortic Lymph Nodes Positive for Tumor by H&E


name: Number of Para-aortic Lymph Nodes Positive for Tumor by IHC Staining Only


name: Number of Pelvic Lymph Nodes Positive for Tumor by H&E


name: Number of Pelvic Lymph Nodes Positive for Tumor by IHC staining only


name: Were Immunophenotype and Cytochemistry Analyses Performed on Bone Marrow Aspirate


name: Number of Primary Tumors in this Location


name: Was Adjuvant Post-operative Radiation Therapy Administered


name: Was Adjuvant Post-Operative Chemotherapy Administered


name: Was Adjuvant Post-Operative Hormone Therapy Administered


name: Was Adjuvant Post-Operative Immunological Therapy Administered


name: Was Adjuvant Post-Operative Pharmaceutical Therapy Administered


name: Was Adjuvant Post-Operative Targeted Molecular Therapy Administered


name: Brimonidine Tartrate Nanoemulsion OCU-300


name: What is the Other Performance Status Scale: Timing


name: What is the Follow-Up Form Completion Outcome Measure of Success


name: Specify Other Performance Status Scale: Timing


name: What is the Procedure Type for New Tumor Event


name: Other Procedure Type for New Tumor Event


name: What is the Status of the Residual Tumor After Surgery for New Tumor Event


name: Was Additional Treatment Administered for New Tumor Event


name: Were Immunophenotype and Cytochemistry Analyses Performed on Peripheral Blood Samples


name: Bone Marrow Aspirate Immunophenotype & Cytochemistry


name: Peripheral Blood Immunophenotype & Cytochemistry


name: Well-Differentiated or De-Differentiated New Tumor


name: Diagnostic Evidence of Recurrence/Relapse


name: Type of New Melanoma Related Tumor Event


name: Did the Individual use Smokeless Tobacco Use at Diagnosis


name: Regular Smokeless Tobacco Use for Six Weeks or More


name: Average Daily Use Smokeless Tobacco after Use for Six Weeks


name: Age When Quit using Smokeless Tobacco after Regular Use


name: Was Evidence of Disease Present after Completion of Therapy


name: Was Tumor Progression Present After Initial Treatment


name: Was Tumor Reoccurrence Present After Initial Treatment


name: Were Local Anesthesia Agents Administered


name: Postmenopausal with no Prior Oophorectomy Status


name: Primary Site of New Non-Melanoma Tumor Event


name: Histological Type of New Non-Melanoma Tumor Event


name: Site of New Distant Metastasis Tumor Event


name: Specify Molecular Abnormalities in Study


name: Days to Absolute Neutrophil Count Greater than 1000 per Microliter


name: Days to Platelet Count Greater than 100,000 per Microliter


name: del(10q23)/PTEN Gene Locus Deletion Analysis


name: del(10q23)/PTEN Gene Locus Deletion Analysis Method


name: EGFR Amplification Analysis Testing Method


name: Percent Blasts in Peripheral Blood at Diagnosis


name: Complete Blood Count from Clinical Peripheral Blood (Within 24 Hours of Banking)


name: Specify Other ERBB2 Non-Exon 20 Mutation


name: MGMT Promoter Methylation Testing Method


name: Is Another Non-Exon 20 ERBB2 Mutation Present


name: Specify Molecular Abnormality Analysis Method


name: SDH Complex Mutation Analysis Testing Method


name: Did Caregiving Responsibilities Make it Difficult to Work the Required Number of Job Hours


name: Did Caregiving Responsibilities Make it Difficult to Get Going Easily at Beginning of Workday


name: Did Caregiving Responsibilities Make it Difficult to Start Job on Arrival at Work


name: Did Caregiving Responsibilities Make it Difficult to do Work Without Stopping For Breaks or Rests


name: Did Caregiving Responsibilities Make it Difficult to Stick to Job Routine or Schedule


name: Have Difficulty with Sitting, Standing, or Staying in One Position Longer than 15 Minutes While Working Due to Caregiving Responsibilities


name: Have Difficulty Repeating Same Motions Repeatedly While Working Due to Caregiving Responsibilities


name: Did Caregiving Responsibilities Make it Difficult to Keep Mind on Work


name: Did Caregiving Responsibilities Make it Difficult to Do Work Carefully


name: Did Caregiving Responsibilities Make it Difficult to Think Clearly When Working


name: Did Caregiving Responsibilities Make it Difficult to Concentrate on Work


name: Did Caregiving Responsibilities Make it Difficult to Work Without Losing Train of Thought


name: Did Caregiving Responsibilities Make it Difficult to Easily Read or Use Eyes When Working


name: Did Caregiving Responsibilities Make it Difficult to Speak With People In-Person, in Meetings, or Phone When Working


name: Did Caregiving Responsibilities Make it Difficult to Control Temper Around People When Working


name: Did Caregiving Responsibilities Make it Difficult to Help Other People to Get Work Done


name: Did Caregiving Responsibilities Make it Difficult to Listen Well to New Information Given at Work


name: Did Caregiving Responsibilities Make it Difficult to Control Feelings of Sadness or Grief When Working


name: Did Caregiving Responsibilities Make it Difficult to Handle Workload


name: Did Caregiving Responsibilities Make it Difficult to Work Fast Enough


name: Did Caregiving Responsibilities Make it Difficult to Finish Work on Time


name: Did Caregiving Responsibilities Make it Difficult to Do Work Without Making Mistakes


name: Did Caregiving Responsibilities Make it Difficult to Feel You've Done What You're Capable of Doing


name: Have Difficulty Doing Usual Household Chore or Activity Because of Caregiving Responsibilities


name: Someone There for Suggestions About How to Deal with Personal Problem


name: Someone There to Love and Make You Feel Wanted


name: Someone There to Get Together for Relaxation


name: Someone There to Help With Daily Chores if Sick


name: Someone There to Perform Caregiving Responsibilities When You Cannot


name: Someone There for Questions or Concerns About Caregiving


name: Being Able to Provide Assistance as Caregiver is Emotionally Rewarding for Me


name: Being Able to Provide Assistance as Caregiver is Spiritually Rewarding for Me


name: Being Able to Provide Assistance as Caregiver Helps Me Feel in Control of Situation


name: Being Able to Provide Assistance as Caregiver is Important to Me


name: Being Able to Provide Assistance as Caregiver is My Duty as Responsible Adult


name: Currently Paying Someone to Assist with Caregiving


name: Plan to Take Leave of Absence From Work Over Next Year Because of Caregiving


name: Was Interferon Gamma Treatment Administered Prior to Specimen Resection


name: Was Interferon Gamma Treatment Administered 90 Days Prior to Specimen Resection


name: Description of Epochs of O2 Desaturation Less than 92% Greater than 5 Minutes Prior to Organ Excision


name: Intraoperative Blood Product Administration


name: Were Other Medications Administered During Surgery


name: Were Steroids Administered During Surgery


name: Other Medications Administered During Surgery Prior to Tumor Tissue Removal


name: Surgery Information Indicate If any of the Following Medications were Administered During Surgery


name: Specify Other Muscle Relaxants Administered


name: Specify Other Narcotics or Opiates Administered


name: Were Other Preoperative IV Medications Administered


name: Were Preoperative IV Antacids Administered


name: Were Preoperative IV Antiemetics Administered


name: Were Preoperative IV Opiates Administered


name: Specify Other Preoperative IV Sedation Administered


name: Was Preoperative IV Sedation Administered


name: Highest Grade Pancreatic Intraepithelial Neoplasia


name: Which Pulmonary Function Tests Were Performed


name: Pathologic Findings in Non-Neoplastic Kidney


name: Prognostic Features Used for Tumor Prognosis


name: Renal Vein or Vena Cava Thrombosis or Other Coagulopathies


name: CPTAC Acute Myeloid Leukemia Baseline Form


name: Prepare and Give Medicines, Fluids, Nutrition Intravenously


name: Prepare and Give Medicine as Shot in Muscle or Under Skin


name: Change Dressing on Your Child's Catheter and Change Catheter Cap


name: Manage Child's Side Effects of Cancer or its Treatment


name: Keep Your Child Comfortable and Without Pain


name: Manage Other Childhood Illnesses for Your Child with Cancer


name: Manage Unexpected Events Related to Your Child's Illness


name: Additional Household Tasks Related to Your Child's Illness


name: Coordinate, Arrange, and Manage Child's Medical Services


name: Travel to and From Hospital for Medical Care


name: How Much Time Spent at Hospital for Appointments


name: How Much Effort or Difficulty for Time Spent at Hospital for Appointments


name: Provide Emotional Support for Your Child with Cancer


name: Provide Emotional Support for Other Children in the Family


name: Provide Emotional Support for Extended Family


name: Comfort Your Child Through Pain of Cancer and its Treatment


name: Take Care of Discipline and/or Behavior Problems of Child with Cancer


name: Take Care of Finances, Bills, and Forms Related to Child's Illness


name: Plan Activities for Your Child with Cancer Around Treatment and Illness


name: Plan Activities for Your Family Around Treatment and Illness


name: Get Child Care or Babysitting Help for Your Ill Child


name: Get Child Care or Babysitting for Siblings of Ill Child


name: Communicate Information About Cancer to Schools, Day Care, Babysitters, Extended Family, and Friends


name: Watch for and Report Your Child's Physical Symptoms and Medical Condition to Medical Team


name: Get Information on Your Child's Illness and Treatment


name: Anything Else You Wish to Tell About Taking Care of Your Child with Cancer


name: CPTAC Uterine Corpus Endometrial Carcinoma Baseline Form


name: CPTAC Lung Squamous Cell Carcinoma and Lung Adenocarcinoma Baseline Form


name: CPTAC Clear Cell Renal Cell Carcinoma Baseline Form


name: CPTAC Head and Neck Squamous Cell Carcinoma Baseline Form


name: CPTAC Glioblastoma Multiforme Baseline Form


name: Regimen Used to Treat Malignant Thymus Neoplasm


name: Regimen Used to Treat Malignant Anal Neoplasm


name: Regimen Used to Treat Chronic Myeloid Leukemia


name: Regimen Used to Treat Merkel Cell Carcinoma


name: Regimen Used to Treat Myelodysplastic Syndromes


name: Regimen Used to Treat Hepatobiliary Cancer


name: Regimen Used to Treat Plasma Cell Neoplasm


name: Regimen Used to Treat Primary Amyloidosis


name: Regimen Used to Treat Malignant Soft Tissue Neoplasm


name: Were IV Narcotic/Opiate Agents Administered


name: Radium Ra 224-labeled Calcium Carbonate Microparticles


name: Validated Hemophilia Regimen Treatment Adherence Scale - On-Demand


name: Validated Hemophilia Regimen Treatment Adherence Scale - Prophylaxis


name: Other Site of New Distant Metastasis Tumor Event


name: Was the Individual Exposed to Second-Hand Smoke


name: Specify Other Inhalation Anesthesia Agents


name: Specify Other Preoperative IV Anesthesia Administered


name: Response Evaluation Criteria In Lymphoma 2017


name: Were Additional Molecular Studies Performed


name: Was 10q23/PTEN Locus Deletion Analysis Performed


name: Was IDH Family Mutation Analysis Performed


name: Was Immunohistochemical Testing Performed


name: Was Additional Immunohistochemical Testing Performed


name: Was Additional Mutation Analysis Performed


name: Was MGMT Promoter Methylation Testing Performed


name: Was SDH Complex Mutation Analysis Performed


name: Was Fluorescence In Situ Hybridization Performed


name: Regimen Used to Treat or Prevent Graft Rejection


name: Autologous Stem Cell Transplant Recipient


name: Allogeneic Stem Cell Transplant Recipient


name: modified Severity Weighted Assessment Tool


name: First Visit Year with All Necessary Components to Determine


name: Specify Site If Distant Metastasis Submitted


name: Struggle with Rent or Mortgage Due to Financial Difficulties


name: Live with Others Due to Financial Difficulties


name: Lack of Reliable Transportation Keeps from Appointments, Meetings, Work, or Daily Living


name: Utility Company Threatened to Shut Off Services for not Paying Bills


name: Utility Company Shut Off Services for not Paying Bills


name: Days Home Not Heated or Cooled Because Bills Not Paid


name: Used Cooking Stove to Heat Home Because Bills Not Paid


name: Telephone Service Disconnected Due to Bill Not Paid


name: Worried Food Would Run Out Before Get Money to Buy More


name: Food Bought Didn't Last and Didn't Have Money to Get More


name: If Lose Current Income Sources and Live Off Savings, How Long Could Continue to Live at Current Address and Standard of Living


name: Family Received Food from Food Pantry or Soup Kitchen


name: Family Received Low-Income or Subsidized Housing


name: Family Received Free or Subsidized School Lunch


name: Specify Number of Lymph Nodes Positive for Tumor by IHC Staining Only


name: Specify Number of Lymph Nodes Positive for Tumor by H&E


name: International Myeloma Working Group Minimal Residual Disease Criteria


name: International Myeloma Working Group Standard Response Criteria


name: Have a Regular Morning Routine in Our Home


name: Try to See Humorous Side of Things When Faced with Problems


name: Having to Cope with Stress can Make me Stronger


name: Tend to Bounce Back After Illness, Injury, or Other Hardships


name: Can Achieve my Goals, Even if There are Obstacles


name: Think of Myself as a Strong Person When Dealing with Life's Challenges and Difficulties


name: Able to Handle Unpleasant or Painful Feelings


name: Treated with Less Courtesy or Respect than Other People


name: Receive Poorer Service Than Other People at Restaurant or Stores


name: People Act as if They Think You are Not Smart


name: Regimen Used to Treat Malignant Bone Marrow Neoplasm


name: Retrograde Selective Washing of Upper Tract


name: Regimen Used to Treat Malignant Intestinal Neoplasm


name: Was a New Tumor Event Present After Initial Treatment


name: Regimen Used to Treat Malignant Fallopian Tube Neoplasm


name: Regimen Used to Treat Malignant Peritoneal Neoplasm


name: Lymphedema Symptom Intensity and Distress Survey - Arm


name: Regimen Used to Treat Malignant Germ Cell Tumor


name: Regimen Used to Treat Malignant Reproductive Endocrine Neoplasm


name: Have Lack of Confidence in Insurance Provider


name: Feel Misunderstood by Spouse or Significant Other


name: Have Inability to Complete Hobbies or Leisure Activities


name: Consistently Decreased Social Activities


name: Symptoms Intensity and Distress Likert Scale


name: Fluorouracil Continuous Infusion Regimen


name: Methotrexate Intra-Cerebrospinal Fluid Regimen


name: Intralesional Interferon Alfa-2b Regimen


name: Talimogene Laherparepvec Intralesional Regimen


name: Rituximab and Hyaluronidase Human Regimen


name: Needed Medical Care or Prescription Medicine but Unable to Afford it


name: Who Needed Medical Care but Family Unable to Afford it


name: Who Needed Prescription Medicine but Family Unable to Afford it


name: Specify Another Form of Birth Control that was Used


name: MLH1 Gene Promoter Hypermethylation Status


name: Was Additional Surgery for New Loco-Regional Tumor Event Performed


name: Was Additional Surgery for New Metastatic Tumor Event Performed


name: Date of Additional Surgery for New Tumor Event: Loco-Regional


name: Date of Additional Surgery for New Tumor Event: Metastatic


name: Antithymocyte Globulin Rabbit/Tacrolimus Regimen


name: Horse Antithymocyte Globulin/Tacrolimus Regimen


name: Rabbit Anti-thymocyte Globulin/Prednisone/Tacrolimus Regimen


name: Equine Anti-thymocyte Globulin/Prednisone/Tacrolimus Regimen


name: Dose-adjusted R-EPOCH Plus High-dose Methotrexate Regimen


name: R-CODOX-M Alternating with R-IVAC Regimen


name: Was ALK Rearrangement Analysis Performed


name: Was BRAF Rearrangement Analysis Performed


name: Was RET Rearrangement Analysis Performed


name: Was ROS1 Rearrangement Analysis Performed


name: Tissue Expander-Implant Breast Reconstruction


name: Was Radiation Administered as an Additional Treatment for a New Tumor Event


name: Was Chemotherapy Administered as an Additional Treatment for a New Tumor Event


name: Was Immunotherapy Administered as an Additional Treatment for a New Tumor Event


name: Was Hormone Therapy Administered as an Additional Treatment for a New Tumor Event


name: Was Targeted Molecular Therapy Administered as an Additional Treatment for a New Tumor Event


name: Was Additional Pharmaceutical Treatment for New Tumor Event Administered


name: Number of Days from Date of Collection to Date of Last Contact


name: Was Bone Marrow Transplantation Performed


name: Specify if Other Cytogenetic Analysis Abnormality Type


name: Discrete Set Telecommunication URL Data Type


name: Regimen Used to Treat Non-neoplastic Hematologic Disorders


name: Are Tumor Infiltrating Lymphocytes Present


name: Test of Word Reading Efficiency, Second Edition


name: Oral Mechanism/Cranial Nerve Examination for Young Children


name: Head and Neck Survivorship Tool: Assessment and Recommendations


name: Computed Spanish/Hispanic Ethnicity Code


name: CDISC Protocol Study Population Attribute Terminology


name: CDISC SDTM Laboratory Analytical Method Calculation Formula Terminology


name: CDISC SDTM Model Version ResponseTerminology


name: CDISC SDTM Implementation Guide Version Response Terminology


name: CDISC Therapeutic Area User Guide Response Terminology


name: CDISC SDTM FDA Technical Specification Response Terminology


name: CDISC SEND Body Irradiation Model Response Terminology


name: CDISC SEND Rad/Nuc Targeted Injury Model Response Terminology


name: CDISC SEND Chemical Challenge Agent Name Response Terminology


name: CDISC SEND Genus and Species Response Terminology


name: Beta-lactamase Positive Bacteria Measurement


name: Beta-lactamase Negative Bacteria Measurement


name: Non-Cogstate Baseline and Follow-up Measures


name: Automated Video-Assisted Smoking Treatment


name: Evidence of Malignant Disease Description


name: CDISC Diabetes Therapeutic Area User Guide Version 1.0 - Supplement for ADaM


name: Robot-Assisted Salvage Pelvic Lymph Node Dissection


name: Robot-assisted Salvage Pelvic Mass Resection


name: Kappa Light Chain to Lambda Light Chain Ratio Measurement


name: Cytochrome P450 2C9 Activity Measurement


name: Progressive Spermatozoa to Total Spermatozoa Ratio Measurement


name: pH Adjusted for Body Temperature Measurement


name: Thyroid Stimulating Immunoglobulin Actual to Control Ratio Measurement


name: APTT-LA Actual to Control Ratio Measurement


name: Thrombin Time Actual to Control Ratio Measurement


name: APTT-LA Screen to Confirm Percent Difference


name: dRVVT Screen to Confirm Percent Difference


name: Choriogonadotropin Adjusted for Maternal Weight Measurement


name: Neisseria gonorrhoeae, Beta-lactamase Positive Measurement


name: Neisseria gonorrhoeae, Beta-lactamase Negative Measurement


name: Multiple Inert Gas Elimination Technique


name: Natural Log Transformed Observed Area Under the Curve Infinity


name: Natural Log Transformed Area Under the Curve From Dosing to Last Concentration


name: CDISC SDTM Implementation Guide Version 3.1.1


name: CDISC SDTM Implementation Guide Version 3.1.2


name: CDISC SDTM Implementation Guide Version 3.1.2 Amendment 1


name: CDISC SDTM Implementation Guide Version 3.1.3


name: CDISC Chronic Hepatitis C Therapeutic Area User Guide Version 1.0


name: CDISC Diabetic Kidney Disease Therapeutic Area User Guide Version 1.0


name: CDISC Duchenne Muscular Dystrophy Therapeutic Area User Guide Version 1.0


name: CDISC Dyslipidemia Therapeutic Area User Guide Version 1.0


name: CDISC Ebola Therapeutic Area User Guide Version 1.0


name: CDISC Influenza Therapeutic Area User Guide Version 1.1


name: CDISC Influenza Therapeutic Area User Guide Version 1.0


name: CDISC Kidney Transplant Therapeutic Area User Guide Version 1.0


name: CDISC Major Depressive Disorder Therapeutic Area User Guide Version 1.0


name: CDISC Malaria Therapeutic Area User Guide Version 1.0


name: CDISC Prostate Cancer Therapeutic Area User Guide Version 1.0


name: CDISC QT Studies Therapeutic Area User Guide Version 1.0


name: CDISC Rheumatoid Arthritis Therapeutic Area User Guide Version 1.0


name: CDISC Schizophrenia Therapeutic Area User Guide Version 1.1


name: CDISC Schizophrenia Therapeutic Area User Guide Version 1.0


name: CDISC Traumatic Brain Injury Therapeutic Area User Guide Version 1.0


name: CDISC Tuberculosis Therapeutic Area User Guide Version 2.0


name: CDISC Vaccines Therapeutic Area User Guide Version 1.1


name: CDISC Virology Therapeutic Area User Guide Version 2.1


name: CDISC Virology Therapeutic Area User Guide Version 2.0


name: CDISC Alzheimer's Therapeutic Area User Guide Version 1.0


name: CDISC Alzheimer's Therapeutic Area User Guide Version 2.0


name: CDISC Asthma Therapeutic Area User Guide Version 1.0


name: CDISC Breast Cancer Therapeutic Area User Guide Version 1.0


name: CDISC Cardiovascular Studies Therapeutic Area User Guide Version 1.0


name: CDISC Colorectal Cancer Therapeutic Area User Guide Version 1.0


name: CDISC COPD Therapeutic Area User Guide Version 1.0


name: CDISC HIV Therapeutic Area User Guide Version 1.0


name: CDISC Huntington's Disease Therapeutic Area User Guide Version 1.0


name: CDISC Multiple Sclerosis Therapeutic Area User Guide Version 1.0


name: CDISC Pain Therapeutic Area User Guide Version 1.0


name: CDISC Pain Therapeutic Area User Guide Version 1.1


name: CDISC Parkinson's Disease Therapeutic Area User Guide Version 1.0


name: CDISC Polycystic Kidney Disease (PKD) Therapeutic Area User Guide Version 1.0


name: CDISC Post Traumatic Stress Disorder Therapeutic Area User Guide Version 1.0


name: US FDA HIV Technical Specifications Guidance v1.0


name: US FDA Vaccines Technical Specification Guidance v1.0


name: US FDA Clinical Endpoint BE Studies v1.0


name: US FDA Study Data Technical Conformance Guide v4.2.1


name: Expected Onset of Rad/Nuc Targeted Injury


name: Chemical Agent Material Identification Code


name: Total Body Irradiation Plus Bone Marrow Transplant


name: Total Body Irradiation with Bone Marrow Not Irradiated


name: Bio-enhanced Curcumin Extract Formulation


name: CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Name Terminology


name: CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Code Terminology


name: CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Name Terminology


name: CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Code Terminology


name: CDISC Questionnaire T1-DDS Test Name Terminology


name: CDISC Questionnaire T1-DDS Test Code Terminology


name: CDISC Clinical Classification AVPU Test Name Terminology


name: CDISC Clinical Classification AVPU Test Code Terminology


name: CDISC Clinical Classification BPRS 1988 Version Test Name Terminology


name: CDISC Clinical Classification BPRS 1988 Version Test Code Terminology


name: CDISC Clinical Classification E-TRIP Test Name Terminology


name: CDISC Clinical Classification E-TRIP Test Code Terminology


name: EORTC QLQ-C15-PAL Version 1 Questionnaire Question


name: EORTC QLQ-C30 Version 3 Questionnaire Question


name: BPRS 1988 Version Clinical Classification Question


name: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0


name: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0


name: Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire


name: Alert Verbal Painful Unresponsive Scale Clinical Classification


name: Brief Psychiatric Rating Scale 1988 Version Clinical Classification


name: Emory Treatment Resistance Interview for PTSD Clinical Classification


name: EORTC QLQ-C15-PAL Version 1 - Trouble Taking Short Walk Outside


name: EORTC QLQ-C15-PAL Version 1 - Stay in Bed or Chair During the Day


name: EORTC QLQ-C15-PAL Version 1 - Need Help Eating, Dressing, Washing


name: EORTC QLQ-C15-PAL Version 1 - Were You Short of Breath


name: EORTC QLQ-C15-PAL Version 1 - Have You Had Pain


name: EORTC QLQ-C15-PAL Version 1 - Have You Had Trouble Sleeping


name: EORTC QLQ-C15-PAL Version 1 - Have You Lacked Appetite


name: EORTC QLQ-C15-PAL Version 1 - Have You Felt Nauseated


name: EORTC QLQ-C15-PAL Version 1 - Have You Been Constipated


name: EORTC QLQ-C15-PAL Version 1 - Were You Tired


name: EORTC QLQ-C15-PAL Version 1 - Pain Interfere Daily Activities


name: EORTC QLQ-C15-PAL Version 1 - Did You Feel Tense


name: EORTC QLQ-C15-PAL Version 1 - Did You Feel Depressed


name: EORTC QLQ-C15-PAL Version 1 - Rate Your Overall Quality of Life


name: EORTC QLQ-C30 Version 3 - Trouble Doing Strenuous Activities


name: EORTC QLQ-C30 Version 3 - Trouble Taking Long Walk


name: EORTC QLQ-C30 Version 3 - Trouble Taking Short Walk Outside


name: EORTC QLQ-C30 Version 3 - Stay in Bed or Chair During the Day


name: EORTC QLQ-C30 Version 3 - Need Help Eating, Dressing, Washing


name: EORTC QLQ-C30 Version 3 - Limited in Work or Daily Activities


name: EORTC QLQ-C30 Version 3 - Limited Hobbies or Leisure Activities


name: EORTC QLQ-C30 Version 3 - Were You Short of Breath


name: EORTC QLQ-C30 Version 3 - Have You Had Pain


name: EORTC QLQ-C30 Version 3 - Did You Need to Rest


name: EORTC QLQ-C30 Version 3 - Have You Had Trouble Sleeping


name: EORTC QLQ-C30 Version 3 - Have You Felt Weak


name: EORTC QLQ-C30 Version 3 - Have You Lacked Appetite


name: EORTC QLQ-C30 Version 3 - Have You Felt Nauseated


name: EORTC QLQ-C30 Version 3 - Have You Vomited


name: EORTC QLQ-C30 Version 3 - Have You Been Constipated


name: EORTC QLQ-C30 Version 3 - Have You Had Diarrhea


name: EORTC QLQ-C30 Version 3 - Were You Tired


name: EORTC QLQ-C30 Version 3 - Pain Interfere Daily Activities


name: EORTC QLQ-C30 Version 3 - Difficulty Concentrating on Things


name: EORTC QLQ-C30 Version 3 - Did You Feel Tense


name: EORTC QLQ-C30 Version 3 - Did You Feel Irritable


name: EORTC QLQ-C30 Version 3 - Did You Feel Depressed


name: EORTC QLQ-C30 Version 3 - Had Difficulty Remembering Things


name: EORTC QLQ-C30 Version 3 - Condition Interfered Family Life


name: EORTC QLQ-C30 Version 3 - Condition Interfered Social Activities


name: EORTC QLQ-C30 Version 3 - Rate Your Overall Health


name: EORTC QLQ-C30 Version 3 - Rate Your Overall Quality of Life


name: T1-DDS - Not Skilled at Managing Diabetes


name: T1-DDS - I Don't Eat Carefully as I Should


name: T1-DDS - Don't Notice Signs of Hypoglycemia


name: T1-DDS - Discouraged See High Blood Glucose


name: T1-DDS - Family Make Bigger Deal Diabetes


name: T1-DDS - Can't Tell Doctor What on My Mind


name: T1-DDS - Too Much Diabetes Equipment With Me


name: T1-DDS - Family Worry About Hypoglycemia


name: T1-DDS - Don't Check Glucose as I Should


name: T1-DDS - Food and Eating Control My Life


name: T1-DDS - Family Act Like Diabetes Police


name: T1-DDS - Be Perfect With Diabetes Management


name: T1-DDS - Hypoglycemic Event While Driving


name: T1-DDS - Subscale 2: Management Distress


name: T1-DDS - Subscale 3: Hypoglycemia Distress


name: T1-DDS - Subscale 4: Negative Social Perceptions


name: T1-DDS - Subscale 7: Friend/Family Distress


name: BPRS 1988 Version - Emotional Withdrawal


name: BPRS 1988 Version - Conceptual Disorganization


name: BPRS 1988 Version - Mannerisms and Posturing


name: BPRS 1988 Version - Hallucinatory Behavior


name: BPRS 1988 Version - Unusual Thought Content


name: Basic Reversed-Phase Liquid Chromatography


name: pH 7.5 Basic Reversed-Phase Liquid Chromatography


name: 2-Dimensional Reversed-Phase Liquid Chromatography


name: Peripheral T-cell Lymphoma Prognostic Index Score


name: Immobilized Metal Affinity Chromatography with Phosphopeptide Enrichment


name: 14-N/15-N Metabolic Labeling Quantification


name: Selected Reaction Monitoring Quantification


name: Label-free Protein Quantification by LC/MS


name: Label-Free Peptide Level Quantification by LC/MS


name: Label-Free Protein Group Level Quantification by LC/MS


name: Label-Free Raw Feature Quantification by LC/MS


name: Label-Free Gene Level Quantification by LC/MS


name: Allogeneic Bone Marrow Transplantation Recipient


name: Autologous Bone Marrow Transplantation Recipient


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Group Identifier


name: Ophthalmic Examinations Group Identifier


name: Urinary System Findings Group Identifier


name: Cardiovascular System Findings Link Identifier


name: Microbiology Susceptibility Link Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Link Identifier


name: Reproductive System Findings Link Identifier


name: Microbiology Specimen Link Group Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Link Group Identifier


name: Reproductive System Findings Link Group Identifier


name: Tumor Identification Link Group Identifier


name: Urinary System Findings Link Group Identifier


name: Cardiovascular System Findings Link Group


name: Cardiovascular System Findings Reference Identifier


name: Functional Tests Sponsor-Defined Identifier


name: Microbiology Specimen Focus of Study-Specific Interest


name: Microbiology Specimen Measurement, Test or Examination Detail


name: Microbiology Susceptibility Non-host Organism Identifier


name: Microbiology Susceptibility Measurement, Test or Examination Detail


name: Microbiology Susceptibility Modified Reported Name


name: Microbiology Susceptibility External File Path


name: Microbiology Susceptibility Analysis Method


name: Microbiology Susceptibility Collected Duration


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Sponsor-Defined Identifier


name: Nervous System Sponsor-Defined Identifier


name: Urinary System Findings Sponsor-Defined Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Elapsed Time


name: Reproductive System Findings Elapsed Time


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Reference Identifier


name: Respiratory System Findings Reference Identifier


name: Urinary System Findings Reference Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Time Point Reference


name: Ophthalmic Examinations Time Point Reference


name: Reproductive System Findings Time Point Reference


name: Proton Multiple Quantum Coherence Magnetic Resonance Spectroscopic Imaging


name: Ophthalmic Examinations External File Path


name: Urinary System Findings Time Point Reference


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Completion Status


name: Nervous System Findings Completion Status


name: Ophthalmic Examinations Completion Status


name: Ophthalmic Examinations Normal or Reference Range Indicator


name: Microbiology Susceptibility Normal or Reference Range Indicator


name: Microbiology Susceptibility Specimen Type


name: Microbiology Susceptibility Agent Concentration Unit


name: Spectral Domain-Optical Coherence Tomography


name: Protein Expression Analysis by Immunohistochemistry


name: Bone Marrow Differential Count within 24 Hours of Banking


name: Navigated Transcranial Magnetic Stimulation


name: Whole Abdominopelvic Intensity-Modulated Radiotherapy


name: Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain


name: Principal Statistical Analysis Plan Version


name: Statistical Analysis Plan Document Version


name: Specify Other Preoperative IV Antacids Administered


name: Specify Other Preoperative IV Antiemetics Administered


name: Revised International Prognostic Scoring System


name: Specify Other Spinal/Epidural Anesthesia Agents Administered


name: Montreal Cognitive Assessment Visuospatial/Executive Test


name: Montreal Cognitive Assessment Attention - Digits Test


name: Montreal Cognitive Assessment Attention - Letters Test


name: Montreal Cognitive Assessment Attention - Subtraction Test


name: Montreal Cognitive Assessment Language - Repeat Test


name: Montreal Cognitive Assessment Language - Fluency Test


name: Montreal Cognitive Assessment Delayed Recall Test


name: Beclomethasone Dipropionate/Formoterol Fumarate Inhalation Solution


name: Submicron Particle Paclitaxel Sterile Suspension


name: BardPort Titanium Implanted Port with Peritoneal Catheter


name: Immune Effector Encephalopathy - ICE Assessment


name: INC Demographic and Maternal Terminology


name: Date of Neonatal Intensive Care Unit Admission


name: Mortality Cut-off Year, National Death Index


name: Stay Focused and Think Clearly Under Pressure


name: CDISC SEND Expected Onset of Rad/Nuc Targeted Injury Response Terminology


name: Fructosamine Corrected for Total Protein Measurement


name: Planned Challenge Agent Exposure Frequency


name: EORTC QLQ-C15-PAL Version 1 - Have You Felt Weak


name: EORTC QLQ-C30 Version 3 - Condition Caused Financial Difficulties


name: T1-DDS - Be Safe From Hypoglycemic Event


name: pH 10 Basic Reversed-Phase Liquid Chromatography


name: Nervous System Findings Group Identifier


name: Bifidobacterium longum/Lactobacillus acidophilus/Enterococcus faecalis Probiotic Supplement


name: Were Subsequent Known Primary Melanoma(s) Found During the Follow-Up


name: Cytogenetic Risk Group-CALGB Criteria for AML


name: menaquinone 500 mcg-100 mcg oral capsule


name: One Touch Ultra2 Syst 024-046 blood glucose m


name: Onetouch Delica Plus Lancing Device 023-973


name: Contact Lens Product Ophthalmic Solution [SALINE SOLUTION]


name: Ointment, Multi Ingredient Topical application Ointment [AVEENO REPAIRING CICA HAND MASK]


name: Ointment, Multi Ingredient Topical application Ointment [AVEENO REPAIRING CICA FOOT MASK]


name: Gel, Multi Ingredient Topical application Gel/Jelly [COPADERM]


name: Cleanser Topical application Soap [AVEENO POSITIVELY RADIANT BRIGHTENING DAILY SCRUB]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 5.5 g in 100 mL / OXYBENZONE 5 g in 100 mL TOPICAL LOTION [Mary Kay Suncare SPF 50 Sunscreen]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 80 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 80 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 9 g in 100 g TOPICAL CREAM [Olay Regenerist Whip Active Moisturizer Broad Spectrum SPF 40 Sunscreen]


name: ALUMINUM SESQUICHLOROHYDRATE 17.6 g in 100 g TOPICAL AEROSOL, SPRAY [Degree]


name: LEVAMISOLE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: OXYBENZONE 3 g in 100 mL / OCTOCRYLENE 1.86 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / AVOBENZONE 2 g in 100 mL TOPICAL LOTION [Glytone Daily Body]


name: TOLAZOLINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: CEFPODOXIME PROXETIL 1 g in 1 g NOT APPLICABLE POWDER


name: ZINC OXIDE 5.6695 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4.5 g in 100 g / HOMOSALATE 6 g in 100 g TOPICAL LOTION [Hawaiian Tropic Matte Effect Mineral Enriched Sunscreen SPF 30]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 159 mg in 1 g TOPICAL STICK [Lady Speed Stick Invisible Dry Power Spring Blossom - antiperspirant/deodorant]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OXYBENZONE 40 mg in 1 g TOPICAL STICK [Softlips Oasis Pineapple Coconut, Peach Mango, Strawberry Kiwi]


name: TEMOZOLOMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: BUTYLSCOPOLAMINE BROMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 17.5 mg in 1 mL TOPICAL CREAM [TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 N365]


name: Avobenzone 30 mg in 1 mL / Homosalate 100 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 50 mg in 1 mL / Oxybenzone 60 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 50 Daily Antiaging Primer with Sunscreen]


name: FAK Care4 Bus and School Yellow ORM D KIT


name: Avobenzone/Octisalate/Octocrylene 3%-5%-10% Topical application Cream [GOLD BOND ULTIMATE NECK & CHEST AGE DEFENSE]


name: ALUMINUM CHLOROHYDRATE 220 mg in 1 g TOPICAL STICK [Toms of Maine Coconut Lavender Antiperspriant / Deodorant]


name: ZINC OXIDE 83.4 mg in 1 g / TITANIUM DIOXIDE 10 mg in 1 g TOPICAL GEL [Blue Lizard Sensitive Face Sunscreen]


name: HYDROXYETHYL CELLULOSE (140 CPS AT 5%) 3.84 g in 240 mL TOPICAL OIL [WeDol Water-based personal lubricant]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Sport Energy Women]


name: Niacinamide 0.60 g in 30 g / Adenosine 0.01 g in 30 g TOPICAL PATCH [Hyalu Plus Up Mask]


name: Niacinamide 0.60 g in 30 mL / Adenosine 0.01 g in 30 mL TOPICAL LIQUID [VIRGIN GRACE Hyalu Plus Serum]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Elements Hurricane]


name: ALUMINUM CHLOROHYDRATE 220 mg in 1 g TOPICAL STICK [Toms of Maine for Men North Woods Antiperspriant Deodorant]


name: ZINC OXIDE 2.8 mg in 30 mL / TITANIUM DIOXIDE 4.3 mg in 30 mL TOPICAL LIQUID [Revlon Youth FX]


name: ZINC OXIDE 5 g in 100 mL / TITANIUM DIOXIDE 7.5 g in 100 mL TOPICAL LOTION [Mineral SPF 40 Moisturizer]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [TimeWise Repair VoluFirm Day Cream SPF 30 Broad Spectrum Sunscreen]


name: ZINC OXIDE 210 mg in 1 g TOPICAL CREAM [Prevention Plus Daily Tinted Moisturizer SPF 30]


name: Dimethicone;Triamcinolone Acetonide 5%; 0.1% Topical application Cream [TRIVIX]


name: AVOBENZONE 1.5 g in 1 g / OCTISALATE 2.5 g in 1 g / OCTOCRYLENE 3.75 g in 1 g TOPICAL CREAM [No7 Early Defence Glow Activating Day Cream]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [TimeWise Repair Volu-Firm Day Cream SPF 30 Broad Spectrum Sunscreen]


name: AVOBENZONE 29.67 mg in 1 mL / OCTISALATE 49.45 mg in 1 mL / OCTOCRYLENE 49.45 mg in 1 mL / HOMOSALATE 98.9 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 50]


name: AVOBENZONE 29.94 mg in 1 mL / OCTISALATE 49.9 mg in 1 mL / OCTOCRYLENE 49.9 mg in 1 mL / HOMOSALATE 74.85 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 30]


name: AVOBENZONE 26.01 mg in 1 mL / HOMOSALATE 130.05 mg in 1 mL / OCTISALATE 43.35 mg in 1 mL / OCTOCRYLENE 86.7 mg in 1 mL TOPICAL SPRAY [Pamana Jack Broad Spectrum SPF 100]


name: AVOBENZONE 29.55 mg in 1 mL / OCTISALATE 49.25 mg in 1 mL / OCTOCRYLENE 49.25 mg in 1 mL / HOMOSALATE 73.875 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 30]


name: AVOBENZONE 16.08 mg in 1 mL / OCTISALATE 40.2 mg in 1 mL / OCTOCRYLENE 16.08 mg in 1 mL TOPICAL SPRAY [Pamana Jack Broad Spectrum SPF 15]


name: AVOBENZONE 19.68 mg in 1 mL / OCTOCRYLENE 19.68 mg in 1 mL TOPICAL LOTION [Panama Jack SPF 8]


name: AVOBENZONE 19.74 mg in 1 mL / OCTISALATE 49.35 mg in 1 mL / OCTOCRYLENE 19.74 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 15]


name: colostomy bag, non-sterile 1 9/16"-2" (12") MISCELL EACH


name: silver/silicone/foam bandage 4" X 4" TOPICAL BANDAGE


name: clindamycin/benzoyl/octinox/octyl/octocryl/oxyben/titanium 1 %-2.5 %-SPF 50 TOPICAL KIT, GEL AND LOTION


name: clindamycin/octinoxate/octyl salicyl/octocryl/oxybenz/titan 1 %-SPF 50 TOPICAL KIT, GEL AND LOTION


name: diclofenac sodium/menthol/camphor 75 mg-3 %-3 % MISCELL KIT, GEL AND TABLET DELAYED RELEASE


name: kit for the preparation of Tc-99m/sodium oxidronate 3.15 mg INTRAVEN VIAL (EA)


name: cardioplegic solution no.26 (maintenance 4:1)


name: cardioplegic solution no.27 (induction 4:1)


name: cardioplegic solution no.28 (reperfusate 4:1)


name: cardioplegic solution no.29 (maintenance 4:1)


name: cardioplegic solution no.30 (induction 4:1)


name: influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen / influenza B virus B/Colorado/06/2017 antigen / influenza B virus B/Phuket/3073/2013 antigen


name: camphor / menthol / methyl salicylate / methylsulfonylmethane


name: DRESSING,OPTIFOAM SITE 4IN X 4IN #MSC1104


name: CATHETER,INTERMITTENT 12FR FEMALE CURE #CQT12


name: CATHERIZATION SET,FOLEY 14FR BARD #772417


name: CATHETER,INTERMITTENT 12FR LOFRIC HYDRO-KIT COUDE #4251240


name: MASK,AEROSOL ADULT FACE TENT MEDLINE #HCS4630


name: TRACH ANTI-DISCONNECT DEVICE,SHILEY #SSDD


name: TUBING,SUCTION 1/4IN X 6FT COVIDIEN #8888301606


name: CATHETER FOLEY 3-WAY 18FR 5ML BARD #70518L


name: DRESSING,OPTIFOAM GENTLE POST-OP 4IN X 8IN #MSC2148


name: CATHETER,INTERMITTENT,GENTLECATH 16FR FEMALE #421574


name: SUCTION TUBE ATTACHMENT DEVICE CARDINAL #501015


name: ADAPTER,NEBULIZER VALVED CAREFUSION #2061


name: LEG BAG STRAP,SPORT,MEDIUM,UROCARE #6343


name: Myocardial late gadolinium enhancement MRI


name: Urinary neutrophil gelatinase-associated lipocalin


name: Percutaneous transhepatic biliary drainage catheter insertion


name: Dental Providers; Dentist, Orofacial Pain


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Gerontological"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Obesity and Weight Management"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Oncology"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Pediatric Critical Care"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Sports Dietetics"


name: Allopathic & Osteopathic Physicians; Preventive Medicine, Addiction Medicine


name: Radiation Oncology Quality Assurance Information System Software


name: Monitors, Cardiac Ventricular Assist System


name: Implantable Sensor Left Atrial Pressure Monitoring Systems


name: Vented Noninvasive Ventilation Interfaces


name: Non-Vented Noninvasive Ventilation Interfaces


name: Sterilization Process Challenge, Packs, Biological/Chemical


name: Hemostatic Agents, Surgical, Non-Absorbable


name: Orthopedic Fixation Systems, Implantable, Spine, Interbody Fusion


name: Orthopedic Fixation Systems, Implantable, Spine, Thoracolumbar, Interbody Fusion, Synthetic


name: Interbody Fusion Devices, Thoracic Spine


name: Cardiopulmonary Resuscitation Automated Assistance Devices


name: Sterilization Process Challenge Packs, Biological


name: Sterilization Process Challenge Packs, Chemical


name: Programmer/Testers, Implantable Cardiac Circulatory Assist Unit


name: Cardiopulmonary Resuscitation Compression Feedback Devices


name: Nucleic Acid Processors, Replication, Thermal Cycle, Digital Polymerase Chain Reaction


name: Interbody Spinal Fusion Implants, Thoracolumbar


name: Software, Information Systems, Healthcare Facility, Clinical, Radiotherapy, Quality Assurance


name: Monitoring Systems, Physiologic, Left Atrial Pressure, Telemetric, Implantable Sensor


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Oronasal


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Nasal


name: Analyzers, Physiologic, Cardiovascular Function, Flow-Mediated Skin Fluorescence


name: Simulators, Training, Extracorporeal Membrane Oxygenation


name: IVD Panels, Human Genetics, Encephalopathy, Brain Malformation, Septo-Optic Dysplasia


name: IVD Panels, Human Genetics, Neuromuscular Disorder, Periodic Paralysis


name: IVD Panels, Human Genetics, Vascular Malformation, Cerebral Cavernous


name: IVD Panels, Human Genetics, Mitochondrial Disorder, Primary Coenzyme Q10 Deficiency


name: IVD Panels, Human Genetics, Blood Disorder, Thrombotic Microangiopathy


name: IVD Panels, Human Genetics, Connective Tissue Disorder, Cutis Laxa


name: IVD Panels, Human Genetics, Encephalopathy, Brain Malformation, Holoprosencephaly


name: IVD Panels, Human Genetics, Neuromuscular Disorder, Collagen VI-Related Myopathy


name: IVD Panels, Human Genetics, Metal Accumulation, Copper/Iron, Mutation


name: Intravenous Poles, Free-Standing, Lift-Assistance


name: IVD Panels, Human Genetics, Pancreatic Disorder, Pancreatitis


name: Surgical Drapes, Patient, Disposable, Abdominal Procedure


name: Masks, Air-Oxygen, Positive Airway Pressure Unit


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Oral


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Total Face


name: Masks, Air-Oxygen, Non-Invasive Positive Pressure Ventilator


name: Procedure Kit/Trays, Irrigation/Lavage, Ostomy


name: Software, Information System, Healthcare Facility, Administrative, Internet of Things Security


name: IVD Panels, Human Genetics, Metabolic Disorder, Metal Accumulation, Comprehensive, Mutation


name: IVD Panels, Human Genetics, Pancreatitis


name: IVD Test Reagent/Kits, Multimodal Assay, Chromosome Anomaly/Gene Anomaly


name: IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, PIK3CA


name: IVD Test Reagent/Kits, Mass Spectrometry, Preeclampsia


name: Hemostatic Agents, Surgical, Oxidized Regenerated Cellulose


name: Hemostatic Agents, Surgical, Polysaccharide Spheres


name: Hemostatic Agents, Surgical, Thrombin-Containing


name: Interbody Spinal Fusion Implants, Cervical


name: Paragangliomas 3 (PGL3) Gene Anomaly Detection


name: Medicare Chronic Condition Special Needs Plan (C-SNP)


name: Medicare Institutional Special Needs Plan (I-SNP)


name: Dual Eligible Special Needs Plan (D-SNP)


name: Fully Integrated Dual Eligible Special Needs Plan (FIDE-SNP)


name: Diclofenac Sodium;Menthol 1.5%; 10% Topical application Solution [DIMENTHO]


name: ReliOn Premier Classic Blood Glucose Monitoring System


name: Gel, Multi Ingredient Topical application Pad [SCARCIN PAD]


name: Solution, Multi Ingredient Topical application Solution [CLEAN & CLEAR LEMON JUICE TONER]


name: Cleanser Topical application Pad [LEADER BABY WIPES]


name: SECNIDAZOLE 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 90 mg in 1 mL / Homosalate 1000 mg in 1 mL / OCTISALATE 202.5 mg in 1 mL / OCTOCRYLENE 640 mg in 1 mL TOPICAL LOTION [baby]


name: AVOBENZONE 90 mg in 1 mL / Homosalate 1000 mg in 1 mL / OCTISALATE 202.5 mg in 1 mL / OCTOCRYLENE 640 mg in 1 mL TOPICAL Lotion [Sunscreen]


name: HOMOSALATE 4.2 g in 28 mL / OCTISALATE 1.4 g in 28 mL / OCTOCRYLENE 2.8 g in 28 mL / AVOBENZONE 0.84 g in 28 mL TOPICAL SPRAY [SnugZ SPF 50 Sunscreen Spry]


name: AVOBENZONE 26.55 mg in 1 mL / HOMOSALATE 88.5 mg in 1 mL / OCTISALATE 44.25 mg in 1 mL / OCTOCRYLENE 44.25 mg in 1 mL TOPICAL SPRAY [Pamana Jack Kids Broad Spectrum SPF 50]


name: AVOBENZONE 29.73 mg in 1 mL / OCTISALATE 49.55 mg in 1 mL / OCTOCRYLENE 49.55 mg in 1 mL / HOMOSALATE 99.1 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 50]


name: AVOBENZONE 29.97 mg in 1 mL / OCTISALATE 49.95 mg in 1 mL / OCTOCRYLENE 99.9 mg in 1 mL / HOMOSALATE 149.85 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 100]


name: OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 17.5 mg in 1 mL TOPICAL CREAM [TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 N203]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL CREAM [Exuviance Daily Corrector with Sunsreen Broad Spectrum SPF 35]


name: TITANIUM DIOXIDE 70 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL LOTION [Exuviance Skin Caring BB Fluid with Sunscreen Broad Spectrum SPF 50]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Aveeno Kids Continuous Protection Sensitive Skin Mineral Sunscreen Broad Spectrum SPF 50]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Axe]


name: AVOBENZONE 30 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL CREAM [Exuviance Age Reverse Day Repair with Sunscreen Broad Spectrum SPF 30]


name: OCTOCRYLENE 16.72 mg in 1 mL TOPICAL OIL [Panama Jack SPF 4 Dark Tanning Oil]


name: OCTOCRYLENE 19.12 mg in 1 mL TOPICAL LOTION [Panama Jack SPF 4]


name: Ketoconazole;Miconazole Nitrate 2%; 2% Topical application Kit [PEDIZOLPAK]


name: AVOBENZONE 90 mg in 1 mL / Homosalate 1000 mg in 1 mL / OCTISALATE 250 mg in 1 mL / OCTOCRYLENE 360 mg in 1 mL TOPICAL Lotion [Sunscreen]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL LIQUID [NATURES CRAFT LIDOCAINE Male Genital Desensitizer]


name: AVOBENZONE 25 mg in 1 mL / HOMOSALATE 60 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF30]


name: AVOBENZONE 25 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Neutrogena Clear Body Breakout Free Oil Free Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Stick Broad Spectrum SPF 50 Plus]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF45]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF55]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 45 mg in 1 mL / OXYBENZONE 40 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 70]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF50]


name: OCTISALATE 20 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Up and Up Illuminating Daily Moisturizer with Sunscreen Broad Spectrum SPF 15]


name: OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OXYBENZONE 60 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Equate Beauty Ultra Light SPF 100]


name: Avobenzone 10 mg in 1 mL / Homosalate 45 mg in 1 mL / Octinoxate 75 mg in 1 mL / Octisalate 45 mg in 1 mL / Oxybenzone 30 mg in 1 mL TOPICAL CREAM [Cicatricure Brightening Face With SPF]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL TOPICAL SPRAY [SPF 30 Scalp and Hair Mist]


name: HOMOSALATE 70 mg in 1 mL / OXYBENZONE 40 mg in 1 mL / AVOBENZONE 20 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL TOPICAL LOTION [HEB Solutions Sunscreen Ultra 30]


name: OCTOCRYLENE 40 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL AEROSOL, SPRAY [Up and Up Sport Sunscreen Broad Spectrum SPF 50]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / OXYBENZONE 30 mg in 1 g TOPICAL STICK [Softlips Vanilla Watermelon]


name: TITANIUM DIOXIDE 0.032 g in 1 mL / ZINC OXIDE 0.077 g in 1 mL TOPICAL CREAM [RECHARGE Protect Blur]


name: HOMOSALATE 100 mg in 1 g / OXYBENZONE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Equate SPF 50 Sport Sunscreen]


name: ZINC OXIDE 216 mg in 1 mL TOPICAL LOTION [Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret with Essential Oils Rose and Charcoal Invisible]


name: ZINC OXIDE 20.2 g in 100 g TOPICAL CREAM [Kerstin Florian Multi-Vitamin Day Creme SPF 30]


name: HOMOSALATE 7 g in 100 g / OCTOCRYLENE 5 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL SPRAY [BANANA BOAT]


name: ISOPROTERENOL HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: TRAMETINIB 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 1.285 g in 50 mL / OCTINOXATE 3.8036 g in 50 mL / OCTOCRYLENE 1.542 g in 50 mL TOPICAL EMULSION [SHISEIDO WHITE LUCENT DAY]


name: TITANIUM DIOXIDE 2 g in 100 g / ZINC OXIDE 18.4 g in 100 g TOPICAL CREAM [NELLY DEVUYST ORGANIC TRANSPARENT MINERAL SUNSCREEN SPF30]


name: Diclofenac Sodium 3% Topical application Gel/Jelly [SOLARAVIX]


name: TELMISARTAN 1 g in 1 g NOT APPLICABLE POWDER


name: CHLORAMPHENICOL PALMITATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: CLEMASTINE FUMARATE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 60 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OXYBENZONE 35 mg in 1 mL TOPICAL CREAM [BB SPF20]


name: OCTISALATE 0.05 g in 1 g / OXYBENZONE 0.06 g in 1 g / HOMOSALATE 0.05 g in 1 g / OCTINOXATE 0.075 g in 1 g / AVOBENZONE 0.01 g in 1 g TOPICAL LOTION [Scrubs Sunscreen]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 13]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 21]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 31]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Leader General Protection SPF 30 Sunscreen]


name: TITANIUM DIOXIDE 0.042 g in 1 g / ZINC OXIDE 0.07 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB SPF42 No23]


name: OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 17.5 mg in 1 mL TOPICAL CREAM [TEINT COUTURE CITY BALM - Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25 N200]


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 40 mg in 1 g / OCTISALATE 40 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL GEL [Neutrogena Hydro Boost City Shield water Broad Spectrum SPF 25]


name: {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack [Trikafta (100 MG / 50 MG / 75 MG; 150 MG)]


name: {30 (24 HR amantadine 129 MG Extended Release Oral Tablet [Osmolex]) / 30 (24 HR amantadine 193 MG Extended Release Oral Tablet [Osmolex]) } Pack [Osmolex 322 MG Daily Dosing]


name: selenium sulfide micronized 52 % to 55.5 % MISCELL POWDER (GRAM)


name: folic acid and methyltetrahydrofolate calcium


name: parenteral electrolytes combination no.31


name: parenteral electrolytes combination no.32


name: parenteral electrolytes combination no.33


name: {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack


name: {30 (24 HR amantadine 129 MG Extended Release Oral Tablet) / 30 (24 HR amantadine 193 MG Extended Release Oral Tablet) } Pack


name: hard maple pollen extract / red maple pollen extract


name: California black walnut pollen extract / English walnut pollen extract


name: oneseed juniper pollen extract / Rocky Mountain juniper pollen extract


name: CATHETER,INTERMITTENT COUDE 14FR COLOPLAST #20024


name: CATHETER,SUCTION 10FR MAXIFLO SMITHS #640010


name: CLEANSING CLOTH,ALOETOUCH PKT M#MSC095228


name: BANDAGE TUBULAR ELASTIC 4IN X 11YD SAG13115


name: DRESSING,ALLEVYN GENTLE BORDER LITE 7.5CM X 7.5CM #66020412


name: DRESSING,COLACTIVE PLUS AG 4IN X 4IN #10340000


name: DRESSING,CUTIMED SORBION SORBACT 4IN X 4IN #7269808


name: DRESSING,CUTIMED SORBION SORBACT 8IN X 12IN #7269811


name: DRESSING,HYDROFERA BLUE HEAVY DRAINAGE 6IN X 6IN HBHD6675


name: DRESSING,OPTIFOAM NON-ADHESIVE 3IN X 3IN #MSC1133F


name: DRESSING,POLYMEM MAX 3.5IN X 3.5IN,FERRIS #606


name: KIT PREP OF TECHNETUM TC-99 OXIDRONATE SODIUM INJ


name: KIT PREP OF TECHNETUM TC-99 TILMANOCEPT INJ


name: SALIVA,ARTIFICIAL (GC DRY MOUTH) GEL,DENT


name: OMRON MICRO Air Vibrating Mesh Nebulizer


name: ReliOn Premier BLU Blood Glucose Monitoring System


name: ReliOn Premier Compact Blood Glucose Monitoring System


name: ReliOn Premier Voice Blood Glucose Monitoring System


name: Cellpad Medical Grade Silicone Gel Matrix


name: Discount Drug Mart Pentips Plus Pen Needles,


name: Blink RevitaLens Multi-Purpose Disinfecting S


name: AMINOCAPROIC ACID 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 16.44 mg in 1 mL / OCTISALATE 41.1 mg in 1 mL / OCTOCRYLENE 16.44 mg in 1 mL TOPICAL SPRAY [Australian Gold Broad Spectrum SPF 15]


name: AVOBENZONE 16.98 mg in 1 mL / OCTISALATE 42.45 mg in 1 mL / OCTOCRYLENE 16.98 mg in 1 mL TOPICAL SPRAY [Australian Gold Instant Bronzer Broad Spectrum SPF 15]


name: AVOBENZONE 19.6 mg in 1 mL / OCTISALATE 49 mg in 1 mL / OCTOCRYLENE 19.6 mg in 1 mL TOPICAL SPRAY [Australian Gold SPF 15 Sunscreen]


name: AVOBENZONE 25.38 mg in 1 mL / HOMOSALATE 63.45 mg in 1 mL / OCTISALATE 42.3 mg in 1 mL / OCTOCRYLENE 42.3 mg in 1 mL TOPICAL SPRAY [Australian Gold Broad Spectrum SPF 30]


name: AVOBENZONE 9.35 mg in 1 mL / OCTOCRYLENE 18.7 mg in 1 mL / OCTISALATE 28.05 mg in 1 mL TOPICAL SPRAY [Australian Gold Instant Bronzer SPF 8 Sunscreen]


name: Avobenzone 30 mg in 1 g / Octisalate 50 mg in 1 g / Octocrylene 70 mg in 1 g TOPICAL CREAM [Lancome Paris Renergie Lift MultiAction Ultra Lifting Firming Dark Spot Correcting Broad Spectrum SPF 30 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 32 mg in 1 mL TOPICAL LIQUID [Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 27 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL TOPICAL LIQUID [Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 26 Sunscreen]